Colleen  Lahey

Colleen Lahey Email and Phone Number

Advisor and Chief Business Officer (Fractional) - AI and ML Health Tech and Life Sciences Funds @ Alumni Ventures
New York, NY, US
Colleen Lahey's Location
New York City Metropolitan Area, United States, United States
Colleen Lahey's Contact Details

Colleen Lahey personal email

About Colleen Lahey

Unique combination of scientific acumen, data analysis, strategic problem solving, and executive-level negotiation skills from experience in biopharma & diagnostic corporate development, clinical & commercial planning, healthcare equity research, investing, and consultingExpert in therapeutic & diagnostic tool market assessments, product & partnership due diligence, revenue & trend forecasting, competitive intelligence, demand estimates for new products, clinical development & trial enrollment challenges, commercialization strategies, TPPs, pricing models, patient access & regulatory processes, and IP/patent/brand lifecycle management Extensive experience working across domains (R&D, commercial, product, legal, finance, marketing, regulatory) and developing and executing strategic initiatives for a broad range of healthcare organizations, from start-ups (proof-of-concept to Series A-G) to large-cap, publicly-traded companies; effective at opportunity sourcing, deal structuring, negotiating term sheets & contracts, alliance management, recruiting advisors, identifying & engaging KOLs, developing founder-investor relations, valuations, M&A, pitch deck creation, and capital raisingStrong command of SaaS, SaMD, biomarkers, AI/ML technologies, LLMs, & GPU-accelerated computing and their applications in the med tech & biopharmaceutical industry via data analysis, predictive & generative modeling, and digital health solutionsVery knowledgeable of differential platform offerings, commercial potential, and the current regulatory & competitive landscape of multiomic technologies (NGS, genomics, transcriptomics, imaging, digital/spatial pathology, proteomics, IHC, ddPCR, LBx, MRD, MCED, ctDNA, cfRNA, single cell seq, AI/ML algorithms as Dx tools, etc)Deep understanding and technical expertise in the following therapeutic categories: Oncology (including somatic & germline genomics, digital pathology (H&E), genetic biomarkers, gene alterations, molecular & AI/ML-based diagnostics, spatial biology technologies), Immunology, Neurology/CNS, Cardiology, Inflammation, Hematology, Cell & Gene Therapy, Gene Editing, Vaccines, Diabetes, Gastroenterology, Pulmonology/Respiratory, Urology, Dermatology, Ophthalmology, Nephrology, Rheumatology, Generics, Women's Health, Biosimilars, and Anti-Aging/Longevity

Colleen Lahey's Current Company Details
Alumni Ventures

Alumni Ventures

View
Advisor and Chief Business Officer (Fractional) - AI and ML Health Tech and Life Sciences Funds
New York, NY, US
Colleen Lahey Work Experience Details
  • Alumni Ventures
    Advisor And Chief Business Officer (Fractional) - Ai And Ml Health Tech And Life Sciences Funds
    Alumni Ventures
    New York, Ny, Us
  • Alumni Ventures
    Advisory Board Member & Interim Cbo
    Alumni Ventures 2022 - Present
    Manchester, Nh, Us
    Advisor to CEOs/Founders in the Health Tech, Life Sciences, and AI & Machine Learning Innovation Funds; leading strategy & business development for VC-backed genomics (Series A), spatial biology (Series C), and cardiac imaging (Series C) startupsAlumni Ventures Group manages $1.3B+ on behalf of alumni members of the Ivy League, Stanford, MIT, etc. It is the largest VC forum in the country for individual investors. We are consistently one of the most active venture capital funds in the U.S. (#1 in 2022 & 2023 - Pitchbook) and co-invest with other leading investors to offer founders fast, low-friction capital to complete their equity raises. We also leverage our sector experience & industry network to advance strategic partnerships and operational efficiencies for our portfolio companies. Funding is generally b/w $50K-$10M during pre-seed to Series B rounds.
  • Tempus Ai
    Senior Director, Corporate & Business Development
    Tempus Ai 2021 - 2023
    Chicago, Il, Us
    Partner with internal & external executive leadership teams (Biopharma R&D, Therapeutic Franchise Leads, Clin Dev, Commercial/Marketing, CDx/Diagnostics, Translational Medicine, Product, Engineering, Genomics/Biomarkers, Regulatory, BD, HEOR, RWE, Legal, Precision Medicine & Medical Affairs teams) to design and execute data-driven diagnostic/therapeutic aligned strategic partnerships, identify patients who will benefit most from targeted therapy, enable registration of therapeutic assets w/ CDx for FDA/EMA approval, and optimize the commercial potential of oncology & immunology assetsDevelop machine learning models of drug response, biomarker discovery, and inform & characterize drug targets and trial design to help rapidly develop the safest, most effective therapeutics. Tempus' artificial intelligence (AI)-driven algorithms platform leverages an expansive clinical-molecular database, CAP/CLIA lab, and pathology & oncology expertise to develop tests that help inform the treatment of cancer patients.Platform offerings: Clinical-molecular-imaging database for project-based licensing, DNA+RNA NGS (3 core clinical-grade assays, including WES & LBx, plus MRD assay in dev), CDx development & planning services, Multi-omics, Biomarker Discovery, Algorithms, H&E (digital pathology algorithms), Clinical Trial Design & Patient Matching programs, Sponsored NGS Testing programs
  • Trevie Research
    Vp, Strategy & Business Development
    Trevie Research 2017 - 2020
    Cambridge, Ma, Us
    Lead & manage clinical operations and alliance partnerships for the ASCENT curative phase 2 clinical trial (sustained MRD negativity per clonoSEQ assay as surrogate endpoint) in High Risk Smoldering Multiple MyelomaOrchestrated clinical trial data collection & analytics for stakeholders including: J&J (daratumumab), BMS/Celgene (lenalidomide), Amgen (carfilzomib), Mayo Clinic, International Myeloma Foundation (IMF), EHR vendors, Veeva Vault, PIs, Trevie Research (Oncology CRO), and site teamsResponsible for the creation, strategy, and execution of a new advisory business within a boutique oncology CRO that leads strategic initiatives for clinical assets & diagnostic assays or IVDs (i.e in-and out-licensing) and accrues investors, SAB members, KOLs & clinical development partnerships
  • Bioct - Connecting Ct'S Bioscience Community
    Biotech Strategic Consultant
    Bioct - Connecting Ct'S Bioscience Community 2006 - 2016
    Groton, Connecticut, Us
    Investor-contracted to partner with drug development executives, academic tech transfer offices, KOLs, and scientific advisory board members to perform market research analysis, competitive intelligence for pipeline products, Go-to-Market (GTM) plans, product forecasts, and value propositions to make Go/No-Go decisions for drug target validationSet data-based milestones for funding rounds and helped create marketing content for investor presentations
  • Cibc
    Director, Equity Research- Pharmaceuticals & Biotech
    Cibc 2002 - 2006
    Toronto, Ontario, Ca
  • Merck & Co. Inc.
    Senior Analyst, Corporate Development
    Merck & Co. Inc. 1996 - 2002
    Merck Capital Ventures (SaaS-based Health Tech Investments) Financial Planning & Analysis (FP&A) Sales/Marketing - Yale-Affiliated Hospital Accounts

Colleen Lahey Skills

Strategic Planning Pharmaceutical Industry Research Investments Corporate Communications Data Analysis Valuation Mergers And Acquisitions Capital Markets Venture Capital P&l Management Biotechnology Life Sciences Project Management Due Diligence Oncology Corporate Finance Private Equity Business Strategy Bloomberg Microsoft Excel Power Point Microsoft Word Microsoft Office Cross Functional Team Leadership Client Relations Management Equity Valuation M&a Analysis Advanced Excel/pivot Tables Writing And Publishing Research Reports Equities Start Ups Business Development Competitive Analysis Financial Analysis Financial Modeling Corporate Development Equity Research Leadership Commercialization Clinical Trials Trend Forecasting Biosimilars Software As A Service Strategic Alliances Licensing Strategic Partnerships Market Research Finance

Colleen Lahey Education Details

  • Columbia Business School
    Columbia Business School
    Healthcare & Pharmaceutical Management
  • University Of Pennsylvania
    University Of Pennsylvania
    Biology & English

Frequently Asked Questions about Colleen Lahey

What company does Colleen Lahey work for?

Colleen Lahey works for Alumni Ventures

What is Colleen Lahey's role at the current company?

Colleen Lahey's current role is Advisor and Chief Business Officer (Fractional) - AI and ML Health Tech and Life Sciences Funds.

What is Colleen Lahey's email address?

Colleen Lahey's email address is co****@****ail.com

What schools did Colleen Lahey attend?

Colleen Lahey attended Columbia Business School, University Of Pennsylvania.

What are some of Colleen Lahey's interests?

Colleen Lahey has interest in Kids, Cooking, Exercise, Investing, Outdoors, Collecting Antiques, Electronics, Home Improvement, Reading, Sports.

What skills is Colleen Lahey known for?

Colleen Lahey has skills like Strategic Planning, Pharmaceutical Industry, Research, Investments, Corporate Communications, Data Analysis, Valuation, Mergers And Acquisitions, Capital Markets, Venture Capital, P&l Management, Biotechnology.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.